Navigation Links
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
Date:8/12/2008

EAST SETAUKET, N.Y., Aug. 12 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that it had filed a patent application for the use of compounds the company is developing for treatment of brain tumors as potential treatments for neurodegenerative diseases including Alzheimer's and Parkinson's Disease.

Dr. John S. Kovach, President and CEO of Lixte, said, "Lixte has developed a series of novel compounds that inhibit the growth of common brain cancers of adults and children in mouse models. We have now found that some variants of these compounds have effects on brain cells that are believed to be potentially useful for the treatment of common neurodegenerative brain diseases. Since Lixte is focused primarily on developing anti-cancer drugs, we are exploring partnerships with companies that have expertise and research programs in the treatment of Alzheimer's Disease."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular abnormalities of common human cancers.

Forward-Looking Statements:

This announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regarding the Company's financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements. These statements are generally accompanied by words such as "intend," anticipate," "believe," "estimate," "potential(ly)," "continue," "forecast," "predict," "plan," "may," "will," "could," "would," "should," "expect" or the negative of such te
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
5. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
6. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
9. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
10. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013  Healthcare providers are turning ... management (ECM) solution, for a deeper ... .  These organizations identified enterprise content management ... use OnBase to optimize their Meditech system ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 ... Gross LLP is investigating claims on behalf of investors ... (NASDAQ: ISRG ) (CUSIP: 46120E602) who purchased ... April 18, 2013 (the "Class Period"). Such investors are ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
(Date:5/22/2013)... , May 22, 2013  MGT Capital Investments, ... will present at the Second Annual Marcum LLP MicroCap ... New York City at the Grand Hyatt ... Chief Executive Officer, will update investors and answer questions. ... The Company,s presentation is scheduled to begin at 9:30 ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4
... Macular ... ... privately held ophthalmic pharmaceutical company, announced today that,enrollment has been completed ... of its lead product, IBI-20089, in patients with,cystoid macular edema. This ...
... ... combination therapy High SVR 24 rate ... Schering-Plough,Corporation (NYSE: SGP ) today reported top-line results from a planned,interim ... protease inhibitor. The analysis showed a high rate of,sustained virologic response (SVR) ...
Cached Medicine Technology:Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
(Date:5/23/2013)... May 23, 2013 After working continuously ... beta testing regimes, Shopping Cart Elite officially ... Redsandmotorsports.com is an Arizona based online store retailing in ... , “Addition of new stores to our clientele has ... Cart Elite, Igor Soshkin. “We are extremely elated with ...
(Date:5/23/2013)... 23, 2013 FindUrgentCare.com launched updates to ... search option for patients. The new advanced feature ... including payment preferences, offered services, insurances accepted and hours ... way to narrow their search and receive targeted results ... provide ambulatory care to walk-in patients in a non-emergency, ...
(Date:5/23/2013)... 2013 Greenville Oral & Maxillofacial ... members and doctors have recently completed their bi-annual ... an Automated External Defibrillator (AED). ... medical device designed to analyze the heart rhythm ... ventricular fibrillation to restore the heart rhythm to ...
(Date:5/23/2013)... 23, 2013 Great defined abs are the ... everyone strives to achieve in the gym yet so many ... not make this goal become a reality. Great abdominal muscles ... often time overlooked. Scott Tischler of Tischler Brothers Fitness explains ... achieve the goal of great abs. , 1.    Go to bed ...
(Date:5/23/2013)... 2013 PhD Box has introduced ... of the research process by offering assistance for Thesis Proposals. ... repertoire of services that the company provides for research consultation ... a dedicated proposal writing service is that this is the ... the research process find it difficult to draft a proposal ...
Breaking Medicine News(10 mins):Health News:Shopping Cart Software Provider, Shopping Cart Elite Officially Announces the Launch Of Redsandmotorsports.com 2Health News:Find Urgent Care Launches New Site Design and Functionality to Provide Advanced Search Options for Users in Need of an Urgent Care Clinic 2Health News:Find Urgent Care Launches New Site Design and Functionality to Provide Advanced Search Options for Users in Need of an Urgent Care Clinic 3Health News:Greenville Oral & Maxillofacial Surgeons Announce CPR Re-Certification 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2
... HOUSTON, Jan. 6 Bederra Corporation (Pink Sheets: BEDA), the ... of Directors has approved a 1 for 400 reverse split ... as of December 03, 2008. The Company has submitted all ... new trading symbol; it began trading on a post-split basis ...
... What and When , Music industry veteran and TV ... Association for a second year to help people living with ... disease, and to encourage them to enroll in The ... 2 diabetes, is coming to Philadelphia to urge the tens ...
... pancreatic cancer patient,has become the first person in Italy ... that potentially enables doctors to improve outcomes while,extending more ... Milan,delivered the faster treatment using RapidArc(TM) radiotherapy technology from,Varian ... "We see three major benefits with ...
... Nutrition Fit For the Whole Family in 2009 Without the ... New Year,s Resolutions, getting fit and eating better are usually ... are healthier than their prepared or quick-service counterparts all too ... Nutritionist Claudia Gonzalez is helping those making the resolution to ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), ... that a group of its first patients are celebrating ... NxStage(R) System One(TM), the first truly portable home hemodialysis ... improved quality of life characterized by better health and ...
... MYL ) today announced that it will present ... 13, at 8:30 a.m. PST at the Westin St. Francis ... and live audio web cast by visiting the Investor Relations, ... clicking on the event icon. Following the live web ...
Cached Medicine News:Health News:Bederra Corp. Approves 1-for-400 Reverse Stock Split 2Health News:Randy Jackson and the American Heart Association Encourage Philadelphia Residents to 'Get In The K.N.O.W.' About Improving Type 2 Diabetes Management 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 3Health News:Nutritionist Claudia Gonzalez Shows How New Year's Resolutions Are Easy to Keep 2Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 2Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 3Health News:First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary 4
Robertazzi Latex Free Nasal Airways are manufactured from soft neoprene and have smooth beveled tip for gentle insertion....
... Soft, flexible Mediprene® material, Available in even ... flexible nasal airway maximizing patient comfort. The ... maximize patient comfort while offering the best ... priced allowing you to offer a quality ...
... of six airways (or nine) airways. ... of lubricating jelly., ,The Latex-Free ... maximize patient comfort while offering the ... is economically priced allowing you to ...
Silkolatex™ . Adjustable flange. Single use....
Medicine Products: